Gut microbiota and GLP-1 modulation
If appropriate, you may begin your first dose the same day
In head-to-head clinical data evaluating the underlying molecules, such as the SURPASS-2 trial comparing high doses of tirzepatide to 1 mg of semaglutide, tirzepatide consistently demonstrated superior reductions in both body weight and HbA1c levels
Click on the JSmol tab to take a closer look at how GLP-1 (PDB 6X18), semaglutide (PDB 7KI0), tirzepatide (PDB 7FIM), and orforglipron (PDB 6XOX) are able to stabilize the active form of the GLP-1 receptor, and compare these structures to that of the inactive GLP-1 receptor (PDB 6LN2)
It aids digestive regularity, which is crucial given the slowed gastric emptying caused by the medication, helping to manage both constipation and potentially diarrhea (depending on the type of fiber and hydration levels)